Insider Purchase: CEO of $NAUT Buys 23,933 Shares
Insider Trading Activity: Sujal M Patel, CEO of $NAUT, purchased 23,933 shares for approximately $23,889, increasing his holdings by about 0.2%, bringing his total to 10,141,721 shares. In the past six months, there have been three insider trades, with two purchases and one sale.
Institutional Investor Movements: In the latest quarter, 41 institutional investors increased their positions in $NAUT stock while 29 reduced theirs, indicating mixed sentiment among institutional stakeholders.
Trade with 70% Backtested Accuracy
Analyst Views on NAUT
No data
About NAUT
About the author
Nautilus (NAUT) Third Quarter 2025 Earnings Call Summary
- Author's Perspective: The views and opinions presented are solely those of the author.
- No Official Endorsement: The content does not necessarily reflect the views of Nasdaq, Inc.
VTYX, MEDP, INBX Surge in After-Hours Trading Following Important Announcements
Ventyx Biosciences Surge: Ventyx Biosciences' shares skyrocketed over 88% after positive Phase 2 trial results for its obesity and cardiovascular risk treatment, VTX3232.
Medpace Holdings Performance: Medpace Holdings saw an 18% increase in shares following better-than-expected Q3 results and an updated fiscal year 2025 guidance.
Inhibrx Biosciences Update: Inhibrx Biosciences' shares rose over 10% as the company announced a live webcast to present topline results from its ChonDRAgon study on ozekibart for chondrosarcoma.
Other Notable Movers: Several biotech stocks, including Acumen Pharmaceuticals and SCYNEXIS, experienced significant after-hours gains, reflecting a broader positive trend in the sector.
